The Glaucoma Treatment Spectrum: Meds, Sustained Delivery, and MIGS

CME Activity Pricing

ASCRS Member Price: FREE
Nonmember Price: FREE

ASCRS gratefully acknowledges the unrestricted educational grants received in support of this program from AbbVie, Glaukos, Mati Therapeutics, and Sight Sciences.


This program is designed as a compact review of key surgical and therapeutic glaucoma treatments. Faculty will explore the various considerations for MIGS, to include standalone and next-generation devices and provide the latest details on glaucoma medical therapy.

Credits: By completing this activity you will earn 1.0 AMA PRA Category 1 Credit™.
Duration: 60 minutes
Activity Expiration Date: May 31, 2024


Leon W. Herndon, MD Nathan Radcliffe, MD


Jacob Brubaker. MD Sahar Bedrood, MD Won Kim, MD Thomas Patrianakos, DO

Learning Objectives



Ophthalmologists attending this program should be able to:

  • Compare and contrast the various MIGS approaches now and in the pipeline for Glaucoma treatment.
  • Describe new and emerging options in glaucoma medical therapy.